News Nov 3, 2022 Alimentiv, Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH)… Read Now
News Oct 5, 2022 Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI-driven technology to Enhance Clinical Trials in IBD and other GI Diseases The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network. London, Ontario, Canada,… Read Now
Article Jun 23, 2022 Take Your Clinical Trial Design from Good to Great Take your clinical trial design from good to great. Poor trial design or planning is the main cause of issues or errors occurring in clinical… Read Now
Article Jun 22, 2022 What are Bioequivalence Studies? What are they? What are bioequivalence studies (BE)? BE studies are a special type of studies designed to compare (i.e., the amount of drug that… Read Now
News Apr 21, 2022 The IBUS Group E.V. and Alimentiv Inc. Announce Partnership to Implement Intestinal Ultrasound Central Reading Services in Clinical Trials for Inflammatory Bowel Disease London, ON, CANADA, Release: January 27, 2022 The International Bowel Ultrasound (IBUS) Group e.V. and Alimentiv Inc. announced today a partnership to offer intestinal ultrasound… Read Now
News Aug 12, 2021 Alimentiv Selects Veeva Vault to Launch eTMF Solution London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering… Read Now
